The comparative cardiovascular and renal effectiveness of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A Scandinavian cohort study
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes"
DOI: 10.1111/dom.14598
Abstract: To assess the comparative cardiovascular and renal effectiveness of sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors versus glucagon‐like peptide‐1 (GLP‐1) receptor agonists in routine clinical practice. read more here.
Keywords: cardiovascular renal; renal effectiveness; sodium glucose; effectiveness sodium ... See more keywords
Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors: Analyses of Real-world Data in Korea
Sign Up to like & getrecommendations! Published in 2018 at "Korean Circulation Journal"
DOI: 10.4070/kcj.2017.0324
Abstract: Background and Objectives To compare cardiovascular disease (CVD) risk associated with 5 different dipeptidyl peptidase-4 inhibitors (DPP-4is) in people with type 2 diabetes. Methods We identified 534,327 people who were newly prescribed sitagliptin (n=167,157), vildagliptin… read more here.
Keywords: peptidase inhibitors; comparative cardiovascular; risks dipeptidyl; cardiovascular risks ... See more keywords